Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-01-26 @ 7:39 PM
Study NCT ID:
NCT01106859
Status:
COMPLETED
Last Update Posted:
2012-02-14
First Post:
2010-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet
Sponsor:
Transcept Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-16
First Submit QC Date:
None
Study First Post Date:
2010-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-15
Results First Submit QC Date:
None
Results First Post Date:
2012-01-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-10
Last Update Post Date:
2012-02-14
Last Update Post Date Type:
ESTIMATED